Orgenics

Our company was established fourteen years ago with one very clear mission in mind: to develop the most sophisticated in-vitro diagnostic system, while maintaining the highest standards of scientific precision. Our ImmunoComb has conquered a special niche in the world of infectious disease diagnosis and our activities extend from our basis in Israel to over 35 countries. Through the World Health Organization and the UNAIDS, which selected our HIV 1&2 ImmunoComb(R) for its global campaign against AIDS, we now serve not only industrialized countries like France & Germany but also most of the developing world. With detection systems for 26 kind of analytes including AIDS, Chlamydia, Hepatitis and Rubella, we offer a complete menu of tests under one single technological platform. Our new product DoubleCheck(TM) brings us now to an even more sophisticated level of immunological testing. Orgenics products are marketed in more than 35 countries. Our distibutors are ready to give the best service to any entity or organization that may need our diagnostic products.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Diagnostics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Europe , North America , Asia , Africa , South America , Near/Middle East , Far East

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: